We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
Advice to give pregnant women on infections that can be transmitted via contact with animals that are or have recently given birth.
The characteristics, management and epidemiology of cryptosporidiosis.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
The surveillance, epidemiology, screening and prevention of chlamydia.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Ministers are receiving regular updates on a Boil Water Notice from South West Water, which remains for 2,500 properties.
Quick reference materials for primary care on diagnosing and understanding culture results for urinary tract infections (UTI).
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The characteristics, diagnosis, management, surveillance and epidemiology of Clostridioides difficile (C. difficile).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).